Clinical Trials in Grenoble, Auvergne-Rhône-Alpes
7 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Stemline Therapeutics, Inc.4,220 enrolled536 locationsNCT06492616
Recruiting
Phase 2
Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients
Metastatic Pancreatic Cancer
Institut du Cancer de Montpellier - Val d'Aurelle162 enrolled8 locationsNCT05065801
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
Lysosomal Acid Lipase DeficiencyWolman DiseaseCholesterol Ester Storage Disease+4 more
Alexion Pharmaceuticals, Inc.300 enrolled104 locationsNCT01633489
Recruiting
Phase 2
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
Metastatic CancerAdvanced CancerMalignant Neoplasm of Lung
Mirati Therapeutics Inc.200 enrolled120 locationsNCT05853575
Recruiting
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
AstraZeneca4,490 enrolled138 locationsNCT06252753
Recruiting
Mental Health and Sexuality in Adolescents and Young Adults
Mental Health IssuePsychiatric DisorderAdolescent Behavior
Fondation Santé des Étudiants de France770 enrolled12 locationsNCT05316948
Recruiting
Tacrolimus Pharmacokinetic Subpopulations
Kidney Transplant Failure and RejectionImmunosuppression-related Infectious Disease
University Hospital, Grenoble180 enrolled2 locationsNCT04526431